The Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration

Aim. To evaluate the short-term efficacy of using a monoclonal antibody fragment (Brolucizumab) for treating neovascular age-related macular degeneration, depending on the morphometric parameters of the retina. Methods: This study included 48 patients (60 eyes) diagnosed with neovascular age-rela...

Celý popis

Podrobná bibliografie

Hlavní autoři:	A. F. Yusupov, M. Kh. Karimova, S. A. Djamalova, D. K. Makhkamova, S. I. Abdullaeva, M. A. Zakirkhodjaeva, Z. A. Khodjaeva, D. A. Rakhimova
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Ukrainian Society of Ophthalmologists 2024-07-01
Edice:	Ukrainian Journal of Ophthalmology
Témata:	аge-related macular degeneration neovascularization optical coherence tomography brolucizumab intravitreal injection
On-line přístup:	https://ua.ozhurnal.com/index.php/files/article/view/130
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!